Search research articles
Contact Us
Filters
Showing results (21-30 of 56) with videos related to
Page
of 6
Sort By:
Aging (Milan, Italy)
|
January 1, 1997
Pituitary-adrenal responses to dexamethasone and CRH administration in patients with untreated Parkinson's disease
E Martignoni, A Costa, R E Nappi, et al.
Electroencephalography and Clinical Neurophysiology
|
February 1, 1993
Changes in motoneuron excitability of masseter muscle following exteroceptive stimuli in Parkinson's disease
E Alfonsi, G Nappi, C Pacchetti, et al.
Acta Neurologica Scandinavica
|
June 1, 1991
Lisuride plus selegiline in the treatment of early Parkinson's disease
G Nappi, E Martignoni, R Horowski, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
July 10, 2001
Botulinum toxin treatment for functional disability induced by essential tremor
C Pacchetti, F Mancini, M Bulgheroni, et al.
Clinical Chemistry
|
May 26, 2001
Plasma homocysteine and l-dopa metabolism in patients with Parkinson disease
F Blandini, R Fancellu, E Martignoni, et al.
Free Radical Biology & Medicine
|
September 1, 1999
Peripheral markers of oxidative stress in Parkinson's disease. The role of L-DOPA
E Martignoni, F Blandini, L Godi, et al.
Functional Neurology
|
May 1, 1995
Terguride in stable Parkinson's disease
E Martignoni, C Pacchetti, B Aufdembrinke, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
November 5, 2003
Sleep attacks in Parkinson's disease: a clinical and polysomnographic study
C Pacchetti, E Martignoni, M Terzaghi, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society
|
March 1, 1991
Disordered pupil reactivity in Parkinson's disease
G Micieli, C Tassorelli, E Martignoni, et al.
Functional Neurology
|
November 1, 1996
Lisuride and bromocryptine in L-Dopa stable-responder parkinsonian patients: a comparative, double-blind evaluation of cardiopressor and neurochemical effects
G Micieli, E Martignoni, A Cavallini, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 56) with videos related to
Sort By:
Page
of 6
Aging (Milan, Italy)
|
January 1, 1997
Pituitary-adrenal responses to dexamethasone and CRH administration in patients with untreated Parkinson's disease
E Martignoni, A Costa, R E Nappi, et al.
Electroencephalography and Clinical Neurophysiology
|
February 1, 1993
Changes in motoneuron excitability of masseter muscle following exteroceptive stimuli in Parkinson's disease
E Alfonsi, G Nappi, C Pacchetti, et al.
Acta Neurologica Scandinavica
|
June 1, 1991
Lisuride plus selegiline in the treatment of early Parkinson's disease
G Nappi, E Martignoni, R Horowski, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
July 10, 2001
Botulinum toxin treatment for functional disability induced by essential tremor
C Pacchetti, F Mancini, M Bulgheroni, et al.
Clinical Chemistry
|
May 26, 2001
Plasma homocysteine and l-dopa metabolism in patients with Parkinson disease
F Blandini, R Fancellu, E Martignoni, et al.
Free Radical Biology & Medicine
|
September 1, 1999
Peripheral markers of oxidative stress in Parkinson's disease. The role of L-DOPA
E Martignoni, F Blandini, L Godi, et al.
Functional Neurology
|
May 1, 1995
Terguride in stable Parkinson's disease
E Martignoni, C Pacchetti, B Aufdembrinke, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
November 5, 2003
Sleep attacks in Parkinson's disease: a clinical and polysomnographic study
C Pacchetti, E Martignoni, M Terzaghi, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society
|
March 1, 1991
Disordered pupil reactivity in Parkinson's disease
G Micieli, C Tassorelli, E Martignoni, et al.
Functional Neurology
|
November 1, 1996
Lisuride and bromocryptine in L-Dopa stable-responder parkinsonian patients: a comparative, double-blind evaluation of cardiopressor and neurochemical effects
G Micieli, E Martignoni, A Cavallini, et al.
Page
of 6